Patients with Heart Failure and CKD often face serious complications beyond their primary disease. One growing concern is hyperkalaemia, a condition that raises potassium levels in the blood. Doctors now view hyperkalaemia as a recurring clinical...
Roche’s blood test breakthrough for early Alzheimer’s detection is drawing global attention after the company received the CE Mark approval in Europe for its Elecsys plasma pTau217 test. The new blood test to detect Alzheimer’s is expected...
In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Debashis Sarkar, SVP & Head Emerging Markets, Aurobindo Pharma, discusses how Indian pharma is building biologics capabilities, balancing generics with innovation,
AIIMS, affordable epilepsy test, and safer epilepsy treatment are now at the center of a major healthcare initiative aimed at improving treatment outcomes for patients across India. The new testing facility, introduced at the Neuroscienc...
India-based Venus Remedies has secured marketing approval in Argentina for its antibiotic drug used to treat serious bacterial infections, marking another step in the company’s global expansion strategy. The approval allows the pharmaceutical...
Aurobindo Pharma has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA) for its Telangana-based oral solid dosage manufacturing unit, marking the successful closure of a key regulatory inspect...
Diabetes treatment access is set to improve in Canada after Orbicular Pharmaceutical Technologies announced it has received a Notice of Compliance (NOC) from Health Canada for its semaglutide injection, developed in partnership with Apotex Inc....
India has launched a nationwide childhood diabetes screening plan, aiming to improve early detection, ensure timely diabetes treatment, and provide long-term child healthcare across the country. The Centre’s new framework focuses on strengtheni...
Aurobindo Pharma’s biosimilars arm CuraTeQ Biologics has secured a major regulatory milestone, as it wins Canada nod for its cancer biosimilar, marking a significant step in the company’s global expansion in oncology treatmen...
India’s pharmaceutical sector is under renewed focus after Lilly supported Haryana’s crackdown on fake Mounjaro drug networks, following the seizure of counterfeit products in Gurugram. The action by the Haryana State Food and Drug Administra...